Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

Analysis of GFAP (Human) by MSD Hypersensitive Multi-Factor Electrochemiluminescence Analyzer (CAT#: STEM-MB-0207-LGZ)

Introduction

Glial Fibrillary Acidic Protein (GFAP) is a marker of astrocyte activation. GFAP is a type III intermediate filament protein that exists as a monomer. GFAP is mainly distributed in the astrocytes of the central nervous system, participates in the formation of the cytoskeleton and maintains its tension strength. It is also expressed in chondrocytes, fibroblasts, myoepithelial cells, lymphocytes, and hepatic stellate cells. However, the GFAP expressed in the peripheral system cannot be detected by the GFAP monoclonal antibody in the central nervous system, suggesting that there may be structural differences between the two sources of GFAP. GFAP may be specific to the nervous system.




Principle

MSD electrochemiluminescence technology is mainly based on ultra-sensitive multi-factor electrochemiluminescence analyzer MES0 Sector600 or Quickplex SQ120. Through dot matrix technology, the detection of 10 indicators per well can be realized in the 96-hole graphite electrode plate. It can also be customized to realize the screening detection of 100 index wells in a 24-well plate.

Applications

Neuroinflammation, Immunology/Inflammation

Procedure

1. Coat the capture antibody on the well plate.
2. Add samples/calibrators.
3. Add detection antibody.
4. Read the plate and analyze the data.

Materials

• Sample Type: Plasma, Serum
Advertisement